Reducing opioid use after aneurysmal subarachnoid hemorrhage: the role of MMA infusion

Headache affects up to 90% of patients following aneurysmal subarachnoid hemorrhage (aSAH), often requiring high-dose opioids that can complicate neurological monitoring. In this episode, JNIS Editor-in-Chief, Dr. Michael Chen, is joined by Professor Peter Kan¹ to discuss a prospective pilot study investigating a novel dural therapy: the infusion of lidocaine (with or without dexamethasone) via the middle meningeal artery (MMA) during aneurysm embolisation. They explore the safety of this targeted approach, its impact on Visual Analog Scale (VAS) pain scores, and its potential as an opioid-sparing strategy in the neuro-ICU. Link to the discussed paper: " Middle meningeal artery infusion for headaches after aneurysmal subarachnoid hemorrhage: a pilot study ". Please

You can listen to Reducing opioid use after aneurysmal subarachnoid hemorrhage: the role of MMA infusion online on Radio and Podcast. Open the player on this page to stream the available audio.

Reducing opioid use after aneurysmal subarachnoid hemorrhage: the role of MMA infusion is an episode from JNIS podcast by BMJ Group.

This episode is 22:41 long.

This episode was published on Mar 31, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JNIS podcast when more episodes are available from the podcast feed.